112 results
Page 2 of 6
6-K
EX-99.1
li49 wbjk
13 Dec 22
Galapagos and CellPoint presented encouraging initial data at ASH 2022 for GLPG5101, a CD19 CAR-T candidate manufactured at point-of-care
7:49am
6-K
EX-99.1
45qjn
7 Nov 22
Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results
6:08am
6-K
EX-99.2
pimnuqye4hi706wkwmfj
7 Nov 22
Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results
6:08am
6-K
EX-99.1
2hxa9ar79 0r
4 Nov 22
Galapagos presents roadmap for pipeline and commercial growth at its R&D Day 2022
4:57pm
6-K
EX-99.1
afbs 7elq
3 Oct 22
Galapagos receives positive CHMP opinion for Jyseleca® European label update based on testicular function safety data from MANTA/RAy studies
6:02pm
6-K
EX-99.1
xhamss7w ij9x77c
8 Aug 22
First key steps in pipeline rebuild and strong commercial progress in H1 2022
4:59pm
6-K
EX-99.2
y2fc 4pf7vw4yb
8 Aug 22
First key steps in pipeline rebuild and strong commercial progress in H1 2022
4:59pm
6-K
EX-99.1
uf52jz3k73l5
23 Jun 22
Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies
11:21am
6-K
EX-99.1
mwojyvuri7to ev
6 May 22
Current report (foreign)
5:18pm
6-K
EX-99.2
73fb3qtmgsbfp8fo5s
6 May 22
Current report (foreign)
5:18pm
6-K
EX-99.2
oavh 0azpg8ea6ojnb
24 Mar 22
Galapagos publishes 2021 annual report and announces Biographies of proposed new board members
8:13pm
6-K
EX-99.1
ni3 k48mvp8
24 Feb 22
Galapagos 2021 results set stage for future growth
5:19pm
6-K
EX-99.2
aphjwm45w e4
8 Nov 21
Galapagos reports commercial and operational progress at Q3 financial results
4:03pm
6-K
EX-99.1
su1xqxytqxr0hdabb
8 Nov 21
Galapagos reports commercial and operational progress at Q3 financial results
4:03pm